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ABSTRACT: In visual transduction, guanylate cyclase-activating proteins (GCAPs) activate the membrane-
bound guanylate cyclase 1 (ROS-GC1) to synthesize cGMP under conditions of low cytoplasmic [Ca2+]free.
GCAPs are neuronal Ca2+-binding proteins with three functional EF-hands and a consensus site for
N-terminal myristoylation. GCAP-1 and GCAP-2 regulated ROS-GC1 activities differently. The myristoyl
group in GCAP-1 had a strong influence on the Ca2+-dependent regulation of ROS-GC1 (shift in IC50).
In contrast, myristoylation of GCAP-2 did not change the cyclase activation profile (no shift in IC50).
Thus, the myristoyl group controlled the Ca2+-sensitivity of GCAP-1, but not that of GCAP-2. The myristoyl
group restricted the accessibility of one cysteine in GCAP-1 and GCAP-2 observed by measuring the
time-dependent thiol reactivity of cysteines. This shielding effect was not relieved when Ca2+ was buffered
by EGTA. We applied surface plasmon resonance (SPR) spectroscopy to monitor the Ca2+-dependent
binding of myristoylated and nonmyristoylated GCAP-1 and GCAP-2 to immobilized phospholipid
membranes. None of the GCAPs exhibited a Ca2+-myristoyl switch as observed for recoverin. Thus, the
myristoyl group controls the Ca2+-sensitivity of GCAP-1 (not that of GCAP-2) by an allosteric mechanism,
but this control step does not involve a myristoyl switch
Neuronal calcium-sensor (NCS)1 proteins constitute a
family of EF-hand Ca2+-binding proteins with a heteroge-
neous expression in various nervous tissue. They are grouped
into five subfamilies named frequenins, visinin-like proteins
(VILIPs), Kv-channel-interacting proteins (KchIPs), recov-
erins, and guanylate cyclase-activating proteins (GCAPs) (1,
2). NCS proteins modulate rather diverse biological phe-
nomena such as, for example, potassium channel inactivation,
repression of transcription, neurotransmitter release, and
second messenger homeostasis. Among NCS proteins, the
GCAPs are probably best understood in their biological
function (3-7). These small acidic Ca2+-sensor proteins are
specifically expressed in photoreceptor cells, where they
regulate the membrane-bound photoreceptor-specific gua-
nylate cyclases (ROS-GC1 and ROS-GC2) in a Ca2+-
dependent manner (8-10). ROS-GCs are activated at low
free [Ca2+] and inhibited at high free [Ca2+]. The cytoplasmic
[Ca2+] in rod and cone photoreceptor cells changes dynami-
cally depending on illumination. In a dark-adapted cell, the
cytoplasmic [Ca2+] is high (500-600 nM) and decreases after
illumination (50-100 nM). Changes in cytoplasmic [Ca2+]
are sensed by Ca2+-binding proteins, e.g., calmodulin,
recoverin, and GCAPs, which control or modulate their target
proteins in a Ca2+-dependent way. These Ca2+-dependent
feedback reactions terminate the photoresponse of the cell,
lead to replenishment of the exhausted cGMP pool and
mediate the regulation of light sensitivity in the cell
(11-14).
All subfamilies of NCS proteins except the KChIPs contain
a consensus site for N-terminal acylation and in principle
could target to membranes by an extruded acyl chain (mainly
myristoyl). Extrusion of the myristoyl group can be triggered
by GDP/GTP exchange, phosphorylation, or Ca2+ in a variety
of signal transduction proteins (15-18). Recoverin, for
example, exhibits a so-called Ca2+-myristoyl switch (19,
20). In its Ca2+-free state, the myristoyl group is buried in a
hydrophobic cleft. It becomes exposed, when Ca2+ binds to
recoverin, and induces a conformational change. Recoverin
is anchored in the membrane by the exposed myristoyl group,
where it inhibits rhodopsin kinase activity in vertebrate
photoreceptor cells (21, 22).
Native GCAP-1 and GCAP-2 resemble recoverin as they
are heterogeneously acylated (mainly myristoylated), but the
biological role of this acylation is only poorly understood
in GCAPs. GCAP-2 does not show a classical, i.e., recoverin-
like, Ca2+-myristoyl switch, and lack of the myristoyl group
in GCAP-2 does not impair or change its regulatory features
(23). In contrast, myristoylated peptides encompassing the
N-terminal region of GCAP-1 can inhibit the GCAP-1-
dependent activation of cyclase (3, 24). A nonmyristoylated
fusion protein of GCAP-1 displayed a lower affinity for the
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cyclase and a shift of its Ca2+-sensitivity (6). In addition,
the inhibition of ROS-GC1 at high [Ca2+] requires the
presence of the myristoyl group in GCAP-1 (25), but
membranes are not necessary to mediate the effect (26). Thus,
it appears that the myristoyl group is critical for the function
of GCAP-1, but it is unclear how it affects the properties of
GCAP-1. We investigated how the myristoyl group influ-
ences some key properties of GCAP-1 in comparison to
GCAP-2. We tested, for example, regulatory properties using
guanylate cyclase assays, membrane binding using surface
plasmon resonance (SPR) spectroscopy, and possible Ca2+-
induced movements of the myristoyl moiety using absorption
spectroscopy of thiol modification.
MATERIALS AND METHODS
Expression of GCAPs. GCAPs were expressed in Escheri-
chia coli as described (24). For the myristoylation of the
N-terminus of GCAPs, the plasmid pBB-131 was used. This
plasmid contains N-terminal myristoyl transferase 1 (NMT1)
from Saccharomyces cereVisiae, kindly provided by Dr. J.
I. Gordon.
Plasmid pET-11a/GCAP was constructed by subcloning
DNA fragments with the GCAP1, D6S-GCAP1, and GCAP2
genes with NdeI/BamHI into the vector pET-11a. D6S-
GCAP-1 is a point mutant of GCAP-1, wherein substitution
of aspartate by serine at position 6 creates a myristoylation
consensus site for yeast N-terminal myristoyl transferase 1
(27).
Bacterial strains Epicurian Coli BL21-CodonPlus(DE3)-
RIL (Stratagene) were used for overexpression of GCAPs.
Cells were cultured in dYT medium at 37 °C. Myristic acid
(100 íg/mL in ethanol) was added to the culture at an OD600
of 0.4. Expression of myristoylated GCAPs was induced by
1 mM IPTG at 37 °C. After 4 h, cells were harvested by
centrifugation for 20 min at 10000g at 4 °C and then
resuspended in 20 mM Tris, pH 7.4, 150 mM NaCl, 2 mM
EGTA or 2 mM CaCl2, 2 mM DTT, and proteinase inhibitor
cocktail mix (Boehringer Mannheim, Germany).
Purification of GCAPs and Isolation of Myristoylated
GCAPs. The overexpressed GCAPs were released from the
BL21-CodonPlus(DE3)-RIL cells by passing through a
French press (SLM Aminco). Subsequent purification of
GCAPs by size exclusion and anion exchange chromatog-
raphy using an A‹ KTA FPLC system (Pharmacia Biotech,
Sweden) was exactly as described (28). Purified GCAPs were
dialyzed against 50 mM ammonium bicarbonate buffer.
Aliquots of 1 mg were lyophilized by a Speedvac concentra-
tor and then stored at -80 °C till further use.
Myristoylated forms of GCAP-1 or GCAP-2 were sepa-
rated from the nonmyristoylated forms by reversed phase
chromatography as described (28). Briefly, each sample was
injected into a Vydac 238TP C18 reverse-phase column (4.6
 250 mm) (Vydac) and eluted with a gradient of 0-80%
(v/v) acetonitrile/0.1% (v/v) TFA at a flow rate of 1.0 mL/
min. The elution was monitored by absorbance at 280 nm.
Preparation of Rod Outer Segment Membranes and
Guanylate Cyclase Assay. Rod outer segments (ROS) were
prepared from freshly collected bovine eyes as described
before (6, 24).
Guanylate cyclase activities were determined with washed
ROS membranes as a source for native ROS-GC1 (the
amount of ROS-GC2 in our bovine ROS preparation is less
than 5% of the ROS-GC1; Hwang et al., in preparation).
Washed ROS membranes were prepared by diluting ROS
5-fold with washing buffer (10 mM Hepes-KOH, pH 7.4, 1
mM DTT) and centrifugation for 10 min at 80 000 rpm in a
Beckman TLA100 centrifuge at 4 °C. The washing procedure
was repeated. The resulting pellet was resuspended in half
of the original ROS volume in resuspension buffer (50 mM
Hepes-KOH, pH 7.4, 500 mM KCl, 20 mM NaCl, 1 mM
DTT). Ten microliters of GCAPs (2 íM) was added to 10
íL of washed ROS membranes to give a total volume of 20
íL. Those reaction samples were preincubated for 5 min at
room temperature with 10 íL of Ca2+/EGTA buffer of
varying free [Ca2+]. Ca2+/EGTA buffer solutions were
prepared as described by Tsien and Pozzan (29). Free [Ca2+]
was calculated with the Ca2+-buffer program CHELATOR
(30) using the constants of Martell and Smith (31). The
cyclase reaction was started by adding 20 íL of Mg2+/GC
buffer (100 mM MOPS, pH 7.1, 140 mM KCl, 20 mM NaCl,
25 mM MgCl2, 5 mM GTP) containing ATP and the PDE
inhibitor zaprinast. Final concentrations of ATP and the PDE
inhibitor zaprinast (Sigma) were 100 íM and 0.4 mM,
respectively. The resulting suspension containing GCAPs and
ROS membranes was incubated for 5 min at 30 °C. The
incubation was stopped by adding ice-cold 50 mM EDTA
and boiling for 5 min.
The activity of ROS-GC1 was determined by a HPLC
chromatography assay using a nucleotide separation protocol
as described before (28). Afterward the solution was
centrifuged for 5 min at 13 000 rpm in a microcentrifuge.
The supernatants (e95 íL) were injected into an HPLC
reversed-phase C18 column (4  250 mm) (Merck, Ger-
many), and nucleotides were eluted with a gradient of
0-70% (v/v) methanol in 5 mM KH2PO4, pH 5.0, at a flow
rate of 1.2 mL/min. The elution was monitored by absorbance
at 254 nm.
The activity unit is nmol of cGMP  min-1  (mg of
Rh)-1. The data were fitted by the modified Hill equation
using the program ORIGIN 6.1 (Microcal Software Inc.,
Northhampton, MA): V/Vmax ) 1 - (Z  [Ca2+]n)/([Ca2+]n
+ IC50n), where V is the activity of ROS-GC1, Vmax is the
maximal activity of ROS-GC1, n is the Hill coefficient, IC50
is the half-maximal value of Ca2+-dependent ROS-GC1
activation, and Z is a constant taking into account that ROS-
GC1 activity is not zero at high free [Ca2+].
Surface Plasmon Resonance (SPR) Measurements. Binding
of GCAPs to lipid membranes was tested by SPR spectros-
copy using the BIAcore technology (BIAcore, Sweden). A
mixture of 2 mg of lipids [40% (w/w) L-R-phosphatidyle-
thanolamine (PE), 40% (w/w) L-R-phosphatidylcholine (PC),
15% (w/w) L-R-phosphatidylserine (PS), 5% (w/w) choles-
terol] in CH3Cl corresponding to the lipid composition in
bovine ROS membranes (32) was lyophilized by a Speed
Vac concentrator. The sample was resuspended in 1 mL of
10 mM Hepes, pH 7.4, 150 mM KCl, 2 mM EGTA and
sonicated at 100 W for 10 min 2 times using a Brandson
B12 sonifier. The suspension was soaked for an hour and
extruded several times through the PC polycarbonate filters
(Corning) with pore diameters of 1 and 0.4 ím. Injection of
recoverin was used as a positive control (33).
Liposomes were immobilized on a Pioneer L1 sensor chip
(BIAcore, Sweden) with 10 mM Hepes, pH 7.4, 150 mM
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KCl, 20 mM MgCl2, 2 mM CaCl2 as running buffer. Pioneer
Chip L1 has a carboxymethylated dextran matrix that has
been modified with lipophilic substances, allowing work with
bilayers. Interaction of GCAPs with lipid membranes was
tested by application of 3 íM GCAPs in 10 mM Hepes, pH
7.4, 150 mM KCl, 20 mM MgCl2, 2 mM CaCl2 or 2 mM
EGTA. The flow rate was 5 íL/min. Nonspecific binding
to membranes was probed by injection of protein G (control
recording).
Thiol ReactiVity of GCAPs. Quantitative determination of
thiol groups in solution was performed by recording the
formation of 5-thio-2-nitrobenzoic acid (TNB) from 5,5′-
dithiobis(2-nitrobenzoic acid) (DTNB) at 412 nm as de-
scribed (34). A fresh solution of DTNB (12.5 mM) was
prepared by dissolving it in 0.1 M Tris, pH 8.0, and
sonicating for 1 min at 80-100 W. Thiol reactivity of
GCAPs was measured by the addition of 100 íM DTNB
into a cuvette containing 0.5 íM GCAPs in 50 mM Hepes,
pH 7.4, 100 mM NaCl and either 100 íM CaCl2 or 2 mM
EGTA. The time course of TNB formation at 412 nm was
recorded after injection of DTNB using a Shimadzu UV-
2101PC UV/VIS scanning spectrophotometer (Shimadzu,
Japan). When samples were preincubated with CaCl2, EGTA
was injected 5 min after application of DTNB. In a second
set of experiments, the order of CaCl2 and EGTA application
was reversed (CaCl2 in excess). The number of reactive
cysteines can be calculated from a calibration curve according
to: A412 ) 0.015 + (0.014  [thiol]free) using cysteine
standard solutions (34).
RESULTS
Myristoylated D6S-GCAP-1 and GCAP-2 were purified
from E. coli cell extracts with high yields (10-50 mg/L).
The D6S mutation was introduced into GCAP-1 to facilitate
myristoylation by yeast NMT in E. coli (27). We verified
the attachment of the myristoyl group by HPLC analysis on
a reversed-phase column (28). GCAPs undergo a Ca2+-
induced conformational change, which can be monitored by
a gel shift assay (3-7). The electrophoretic mobility is higher
in the presence of Ca2+ and lower in the presence of EGTA.
We applied this shift assay to all four proteins (myr-D6S-
GCAP-1, nonmyr-GCAP-1, myr-GCAP-2, and nonmyr-
GCAP-2 in Figure 1A). The extent of this shift was
determined from a plot of the relative mobility as a function
of the molecular mass using molecular weight standards to
create a calibration curve (Figure 1B). Purified myristoylated
GCAPs exhibited an electrophoretic mobility shift of 4.8-
4.9 kDa, nonmyristoylated GCAPs of 4.5 kDa (Figure 1 and
Table 1). These results indicate that a similar Ca2+-induced
conformational change occurs in the myristoylated and
nonmyristoylated forms of GCAPs. However, the shift was
slightly larger (4.8-4.9 versus 4.5 kDa) when the myristoyl
group was present. This might reflect subtle differences in
hydrodynamic shape or conformation between nonmyris-
toylated and myristoylated forms.
Regulation of Guanylate Cyclase ActiVity. GCAPs operate
in visual cells as Ca2+-sensitive regulators of membrane-
bound guanylate cyclases (ROS-GC1 and ROS-GC2). We
used native bovine ROS membranes to test the influence of
the myristoyl group on the activation of ROS-GC1 by
GCAPs (more than 95% of the two guanylate cyclases in
bovine ROS membranes is ROS-GC1; see also Materials and
Methods). Samples were incubated in the presence and
absence of 2 íM GCAP-1 or GCAP-2 forms and varying
[Ca2+]free (Figure 2 and Table 2). The maximal activity of
ROS-GC1 at low [Ca2+]free was higher, when the myristoyl
group was attached. In addition, the x-fold activation (i.e.,
the ratio of cyclase activity at low and high [Ca2+] in the
presence of GCAPs) was also higher, when the myristoyl
group was present. Although nonmyr-GCAP-2 exhibited a
FIGURE 1: Electrophoretic mobilities of GCAPs. (A) Purified
myristoylated (myr) and nonmyristoylated (nm) GCAPs exhibited
an electrophoretic mobility shift in a 15% SDS-PAGE, when CaCl2
was replaced by EGTA. The myristoylated D6S-mutant of GCAP-1
was used. The faint band above myr-GCAP-2 represents nonmyr-
GCAP-2. (B) A calibration curve of molecular weight standards
created from plotting the relative mobility (Rf) of standards versus
their molecular mass (M.W.). Standards were phosphorylase b (97.4
kDa), bovine serum albumin (66 kDa), ovalbumin (45 kDa),
carbonic anhydrase (29 kDa), soybean trypsin inhibitor (20.1 kDa),
and R-lactalbumin (14.2 kDa). Rf-values of GCAPs in the presence
of CaCl2 (open circles) or EGTA (closed circles) are located on
the linear slope of the plot. The corresponding values of the exact
apparent MW are listed in Table 1.
Table 1: Comparison of Relative Electrophoretic Mobility and
Apparent Molecular Weight of myr-D6S-GCAP-1, nonmyr-GCAP-1,
myr-GCAP-2, and nonmyr-GCAP-2 by SDS-PAGE Analysis
apparent MW
(kDa) with
type
theoretical
MW (kDa) EGTA Ca2+
¢MW(EGTA-Ca2+)
(kDa)
myr-D6S-GCAP-1 23.6 26.2 21.4 4.8
nonmyr-GCAP-1 23.4 26.4 21.9 4.5
myr-GCAP-2 23.8 25.6 20.7 4.9
nonmyr-GCAP-2 23.6 26.8 22.3 4.5
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lower maximal activity than nonmyr-GCAP-1 [7.97 versus
11.11 nmol of cGMP  min-1 (mg of Rh)-1], the x-fold
activation was 3 times higher in the case of nonmyr-GCAP-2
(Figure 2 and Table 2). This is mainly due to a stronger
inhibitory effect of GCAP-2 at high [Ca2+] (g1 íM in Figure
2), which is clearly visible with myristoylated and nonmyris-
toylated GCAP-2 (Figure 2C,D) and only slightly apparent
with myr-D6S-GCAP-1 (see data points g100 íM [Ca2+] in
Figure 2A), but it was not observed with nonmyr-GCAP-1
(Figure 2B).
One hallmark of GCAP function is the cooperative
activation of ROS-GCs, when [Ca2+]free decreases (3-10).
Myristoylation did not change the activation profile of
GCAP-2; for example, the half-maximal activation (IC50) and
Hill coefficients (n) were very similar (Table 2) for myris-
toylated and nonmyristoylated GCAP-2. However, the
myristoyl group in GCAP-1 had a strong influence on the
Ca2+-dependent regulation of ROS-GC1. Lack of myristoy-
lation caused a 2-fold shift of the IC50 value and a complete
loss of cooperativity (Figure 2A,B, Table 2). We conclude
from these results that the myristoyl group controls the Ca2+-
sensitivity of GCAP-1, but not that of GCAP-2.
Interaction of GCAPs with Membranes Monitored by SPR
Spectroscopy. Some NCS proteins such as recoverin exhibit
a Ca2+-myristoyl switch, i.e., a Ca2+-dependent association
of the protein with membranes (1, 2). The myristoyl group
serves as an anchor to tether the protein to the surface of
the membrane. SPR spectroscopy was previously used to
investigate the dynamics of the Ca2+-myristoyl switch of
recoverin (33) and neurocalcin (35). We here used a similar
approach to study the membrane association of GCAP-1 and
GCAP-2 forms. Phospholipids were immobilized on a sensor
chip surface. These immobilized lipid layers were sufficiently
stable to allow the recording of binding signals. Protein
samples were injected into the flow cell of the system
(BIAcore), and changes in resonance units were recorded
as a function of time to yield sensorgrams as shown in Figure
3. We recorded the binding of proteins in the presence of
either Ca2+ or EGTA. Myristoylated recoverin served as
positive control, because its Ca2+-myristoyl switch is well
documented and can be monitored by SPR spectroscopy (33).
Protein G was injected to measure any nonspecific associa-
tion of a protein with membranes and to determine changes
in bulk refractive index. The Ca2+-myristoyl switch of
recoverin is manifest as a large amplitude of the SPR signal
in the presence of Ca2+ and a small amplitude in the presence
of EGTA. Binding signals of recoverin obtained in the
presence of EGTA had a slightly higher amplitude than the
control recordings with protein G (Figure 4A). In contrast,
sensorgrams obtained with GCAP-1 and GCAP-2 exhibited
several significant differences when compared with control
recordings (Figures 3 and 4). Amplitudes recorded 7 min
after injection (black bar in Figure 3 indicates injection of
protein) were similar in sensorgrams with myrD6S-GCAP-
1, nonmyr-GCAP-1, and nonmyr-GCAP-2, no matter whether
Ca2+ or EGTA was present (Figures 3 and 4A).
Examples of sensorgrams in Figure 3 show higher
amplitudes for myr-D6S-GCAP-1, nonmyr-GCAP-1, and
nonmyr-GCAP-2 in the presence of EGTA than in the
presence of Ca2+. However, recordings from at least four
different experiments showed that these differences were not
FIGURE 2: Regulation of ROS-GC1 by GCAPs. Washed bovine ROS membranes containing ROS-GC1 were reconstituted with 2 íM
GCAPs at varying [Ca2+]free (closed circles). Control incubations (open circles) were without added GCAPs. (A) myr-D6S-GCAP-1; (B)
nonmyr-GCAP-1; (C) myr-GCAP-2; and (D) nonmyr-GCAP-2.
Table 2: Regulation of ROS-GC1 by GCAPsa
type
maximal
activity
x-fold
activation
IC50[Ca2+]free
(íM)
n, Hill
coefficient
myr-D6S-GCAP-1 17.90 ( 0.56 9 1.088 ( 0.129 1.7
nonmyr-GCAP-1 11.11 ( 0.41 3 2.240 ( 0.776 0.8
myr-GCAP-2 13.85 ( 0.18 14 0.209 ( 0.007 2.4
nonmyr-GCAP-2 7.97 ( 0.05 9 0.214 ( 0.004 2.7
a Activity is expressed as nmol of cGMP  min-1  (mg of Rh)-1.
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statistically significant (Figure 4). Interestingly, myr-GCAP-2
always showed a larger amplitude in the presence of EGTA
(Figures 3 and 4A), which is consistent with a previous
observation by Olshevskaya et al. (23) that GCAP-2 associ-
ates with ROS membranes at low free [Ca2+] and is released
from membranes at high [Ca2+]. Furthermore, it is noticeable
that recordings in the presence of EGTA were higher with
GCAPs than with recoverin (Figure 4A).
A summary of these data is shown in Figure 4B;
amplitudes recorded in the presence of Ca2+ (RUCa2+) were
divided by the amplitudes recorded in the presence of EGTA
(RUEGTA). Values above 1 show the working of a Ca2+-
myristoyl switch (myristoylated recoverin as positive con-
trol), and values around 1 indicate no operation of this switch.
Thus, we conclude that GCAP-1 and GCAP-2 do not perform
a classical Ca2+-myristoyl switch as recoverin.
Thiol ReactiVity of Cysteines in GCAPs. GCAP-1 and
GCAP-2 contain four and three cysteines, respectively. The
four cysteines in GCAP-1 are accessible to the thiol-
modifying reagent DTNB, but the accessibility of one
cysteine (C106) depends on the complete chelation of Ca2+
(34). We tested whether the thiol reactivities of cysteines in
GCAP-1 and GCAP-2 depend on Ca2+ and the presence of
the myristoyl group. Reaction of DTNB with free thiol
groups leads to an increase in the absorbance at 412 nm.
When nonmyr-GCAP-1 was preincubated with 100 íM
CaCl2, injection of DTNB caused a change in absorbance at
412 nm that corresponds to the modification of three
cysteines (trace 1 in Figure 5A). Injection of EGTA then
triggered an additional reaction of DTNB with the fourth
cysteine (arrow pointing to trace 1 in Figure 5A). When
nonmyr-GCAP-1 was first incubated with EGTA, DTNB
reacted immediately with all four cysteines (trace 2 in Figure
5A). However, in myr-D6S-GCAP-1 only two cysteines
reacted with DTNB in the presence of Ca2+, and addition of
EGTA caused the exposition of one additional cysteine (trace
1 in Figure 5B). Reversing the injection of Ca2+ and EGTA
led to the modification of three cysteines. Thus, when
GCAP-1 was myristoylated, one cysteine did not react with
DTNB.
Injection of DTNB into a solution of nonmyr-GCAP-2
caused a reaction with all three cysteines (Figure 5C).
Reversing the order of Ca2+ and EGTA addition (trace 2 in
Figure 5C) yielded a nearly identical recording. When we
used myr-GCAP-2, only two cysteines were accessible to
DTNB. One cysteine did not react with DTNB irrespective
of the order of Ca2+ and EGTA addition (Figure 5D). We
conclude from these results that the myristoyl group has a
strong shielding effect in GCAP-1 and GCAP-2. This
shielding effect is not relieved when the [Ca2+] is changed.
DISCUSSION
GCAP-1 and GCAP-2 undergo a major conformational
change upon binding of Ca2+. Limited proteolysis of Ca2+-
bound GCAP-1 by trypsin cleaves off the myristoylated
N-terminus and the C-terminus, but leaves most of the protein
intact. The Ca2+-free form is more vulnerable to proteolysis
and degraded to smaller fragments (36). Tryptophan fluo-
rescence spectroscopy had shown that this conformational
change occurs around EF-hand 3 (37). GCAP-2 also changes
its conformation by binding of Ca2+ as revealed by UV-
CD and NMR spectroscopy, and its myristoylated N-terminus
is solvent-exposed in the Ca2+-bound and Ca2+-free states
(38). Thus, in both proteins, the myristoyl group is probably
not sequestered into a hydrophobic pocket when Ca2+ is
absent and extruded when Ca2+ is bound, as described for
FIGURE 3: Binding of GCAPs to immobilized liposomes monitored by SPR spectroscopy. Liposomes were immobilized on a L1 sensor
chip (BIAcore). GCAPs were suspended in SPR running buffer containing either CaCl2 or EGTA and injected into the flow cell at a
concentration of 3 íM (black bar). Running buffer (open bar) was the same before and after injection and contained either CaCl2 or EGTA.
Recordings were obtained with myr-D6S-GCAP-1 (A), nonmyr-GCAP-1 (B), myr-GCAP-2 (C), and nonmyr-GCAP-2 (D).
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recoverin (39, 40). So far, structural information of the exact
location of the myristoyl group is lacking; only the three-
dimensional structure of nonmyristoylated GCAP-2 has been
resolved (41). The different accessibilities of free cysteines
in myristoylated and nonmyristoylated GCAPs represent a
new approach to investigate the location and dynamics of
the myristoyl group. In both GCAPs, the myristoyl group
exerts a shielding effect for one cysteine. Although both
GCAPs undergo a conformational change upon binding of
Ca2+ (see also Figure 1 and Table 1), this change does not
cause a significant rearrangement of the myristoyl group,
since the chemical reaction of one cysteine with DTNB is
further prevented. However, the myristoyl group probably
does not protect the particular cysteine from modification
by direct interaction. Spectroscopic and proteolysis data
indicate the permanent exposition of the myristoyl group to
the solvent (36, 38); thus, it might not be in direct vicinity
of the corresponding cysteine. Therefore, it is tempting to
speculate that the myristoyl group acts as an allosteric
regulator of GCAPs that influences the Ca2+-induced con-
formational change without participating in a structural
change. Our data on the activation profiles of ROS-GC1
support this model for GCAP-1. The strong cooperative
Ca2+-dependent activation by myr-D6S-GCAP1 (and also by
native wild-type GCAP-1; see references 3-7) was lost when
nonmyr-GCAP-1 was assayed (Figure 2 and Table 2),
indicating a loss of allostery. However, this was not observed
for GCAP-2 and points to one of several significant differ-
ences between GCAP-1 and GCAP-2.
Exposition of the myristoyl group does not facilitate the
binding to immobilized phospholipids (Figures 3 and 4),
because we did not observe significant differences in
amplitudes of SPR recordings between myristoylated and
nonmyristoylated proteins (Figures 3 and 4A). Only myris-
toylated GCAP-2 showed stronger association with mem-
branes in the absence of Ca2+, but an “inverse Ca2+-
myristoyl switch” is probably not operating (41). Initial
titration experiments indicated that the affinity of GCAPs
for membranes is in the lower micromolar range (J.-Y.
Hwang and K.-W. Koch, unpublished observation), which
is expected for protein-membrane interaction driven by
weak hydrophobic and a small contribution of electrostatic
forces (17). The three-dimensional structure of Ca2+-bound
nonmyristoylated GCAP-2 shows a hydrophobic patch
formed by residues from EF-hand 1 and EF-hand 2 (41).
Since EF-hand 1 is required for targeting to photoreceptor
guanylate cyclase (42), aromatic and aliphatic residues in
EF-hand 2 could participate in membrane binding. In the
Ca2+-free state of myristoylated GCAP-2, hydrophobic and
charged residues might become more exposed and increase
the binding affinity for membranes.
We noticed that dissociation of GCAPs from immobilized
membranes contained a slower component in the presence
of EGTA (Figure 3); however, with nonmyr-GCAP-2 this
was not visible. In our test system, immobilized phospho-
lipids and soluble GCAPs, this observation indicates a more
efficient tethering of Ca2+-free GCAPs to the lipid layer.
However, we did not apply a full quantitative evaluation to
this effect, because the dissociation and association phases
seemed to depend on a variety of factors and did not show
exactly the same profiles in different recordings. Therefore,
we restricted the quantitative evaluation of sensorgrams
(Figure 4) to the amplitudes. A reliable descripton of the
kinetic processes will be the focus of a future study.
A striking difference between GCAP-1 and GCAP-2 was
also observed in activation of ROS-GC1 (Figure 2 and Table
2). The myristoyl group had a stronger influence on the
properties of GCAP-1 than of GCAP-2. In particular, the
Ca2+-sensitivity of GCAP-1, but not that of GCAP-2, is
controlled by an attached myristoyl group. A shift in the
Ca2+-sensitivity was previously observed for a fusion
construct of GCAP-1 that contained a short sequence of six
amino acids instead of a myristoyl group at the N-terminus
(6). Thus, a peptide extension of the N-terminus appears to
mimic the effect of the myristoyl group. Nonmyristoylated
GCAP-1 was less active at low [Ca2+], but at high [Ca2+],
inhibition of ROS-GC1 was also lower than with myr-D6S-
GCAP-1 (Figure 2B and Table 2). A similar effect was
FIGURE 4: Amplitudes of SPR signals. (A) SPR resonance signals
(¢Req) were obtained by binding of proteins to lipid membranes in
the presence of Ca2+ (blank columns) and in the presence of EGTA
(striped columns). Control recordings were obtained with protein
G. (B) Amplitudes of SPR resonance signals in the presence of
Ca2+ were divided by the signal in the presence of EGTA. A ratio
that was significantly higher than 1 was only observed with
myristoylated recoverin (myr-Rec). Data are the mean ( SD of at
least four recordings.
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observed with a truncated mutant of GCAP-1 that lacked
the first 10 amino acids at the N-terminus (25). Thus, the
Ca2+-induced “activator to inhibitor” transition of GCAP-1
is promoted by the myristoyl group. Although this transition
works even more powerful in GCAP-2 (43), the myristoyl
group did not affect this transition in GCAP-2.
Recently, Mendez et al. (44) had shown that transgenic
mice lacking expression of GCAP-1 and GCAP-2 had lost
the Ca2+-sensitivity of guanylate cyclase. Expression of
GCAP-2 in these double knock-out mice restored the Ca2+-
sensitivity of cyclase. However, normal recovery kinetics of
the flash response were only restored by expression of
GCAP-1 (45), but not by expression of GCAP-2 (44). Our
results on different Ca2+-sensitivities of GCAPs (Table 2 and
Figure 2A,C) indicate that GCAP-1 activates cyclase over a
wider range of free [Ca2+] than GCAP-2 does. GCAP-1 is
switched on, when the cytoplasmic [Ca2+] starts falling from
its high dark value. GCAP-1 would therefore significantly
participate in shaping the early rapid phase of the recovery
kinetics of a flash response as observed by Howes et al. (45).
In this model, GCAP-2 is switched on (Figure 2C), when
[Ca2+] has fallen to a lower steady-state value (>200 nM).
GCAP-2 activates ROS-GC1 to a similar maximal activity
as GCAP-1 does, which is consistent with the observation
that expressison of GCAP-2 on a GCAP double knock-out
background can restore maximal light-induced guanylate
cyclase activity (44).
In summary, we have shown that GCAP-1 and GCAP-2
differ in their use of an attached myristoyl group. Recent
findings on other NCS proteins such as hippocalcin, NCS-
1, and neurocalcin ä have demonstrated that closely related
Ca2+-sensor proteins can use their myristoyl groups in
different ways (46). This is rather surprising, since the known
three-dimensional structures of some NCS proteins (41, 47,
48) resemble in their overall fold the structure of recoverin
(39, 40). Therefore one would expect a similar Ca2+-
myristoyl switch as a trigger for translocation to the
membrane. However, the opposite seems to be true; the
myristoyl group fulfills a specific task in each NCS protein.
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